Yang Liu's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 18,000 Option to Purchase Common Stock done . Disclosure was reported to the exchange on Sept. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2025 | 18,000 | 18,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnostics Inc | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 18,867 | 18,867 | - | - | Restricted Stock Units | |
| Insight Molecular Diagnostics Inc | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnostics Inc | James Yang Liu | Sr Dir., Cntlr, PAO, Int PFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnostics Inc | James Yang Liu | Controller, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 57,065 | 57,065 | - | - | Option to Purchase Common Stock | |
| Future FinTech Grp Inc | Yang Liu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2021 | 40,000 | 40,000 (0%) | 0% | 0 | Common Stock |